Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengran Yang

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Acta Neuropathologica|August 29, 2019
The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportionZeran Li, Fabiana H G Farias, Umber Dube, et al.
NPJ Parkinson'S Disease|July 8, 2023
Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson's diseaseBridget Phillips, Daniel Western, Lihua Wang, et al.
Acta Neuropathologica Communications|November 20, 2020
Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson diseaseLaura Ibanez, Jorge A Bahena, Chengran Yang, et al.
Nature Genetics|November 11, 2024
Genetic architecture of cerebrospinal fluid and brain metabolite levels and the genetic colocalization of metabolites with human traitsCiyang Wang, Chengran Yang, Daniel Western, et al.
Research Square|June 19, 2023
Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and informs causal proteins for Alzheimer's diseaseCarlos Cruchaga, Dan Western, Jigyasha Timsina, et al.
Science Translational Medicine|July 5, 2023
Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer's diseaseYun Ju Sung, Chengran Yang, Joanne Norton, et al.
The Lancet. Neurology|May 13, 2026
Identification of genetic modifiers of autosomal dominant Alzheimer's disease: a genome-wide association studyMaulikkumar Patel, Wei Feng, Nicole S Mckay, et al.
Molecular Neurodegeneration|January 3, 2024
Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's diseaseLihua Wang, Niko-Petteri Nykänen, Daniel Western, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
CSF turnover reshapes biomarker interpretation in neurodegeneration studiesPablo García-González, Raquel Puerta, Jonas Dehairs, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Human CSF proteogenomics links genetic variation to neurodegenerative disease proteinsRaquel Puerta, Pablo Garcia-Gonzalez, Itziar de Rojas, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Acta Neuropathologica|August 29, 2019
The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportionZeran Li, Fabiana H G Farias, Umber Dube, et al.
NPJ Parkinson'S Disease|July 8, 2023
Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson's diseaseBridget Phillips, Daniel Western, Lihua Wang, et al.
Acta Neuropathologica Communications|November 20, 2020
Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson diseaseLaura Ibanez, Jorge A Bahena, Chengran Yang, et al.
Nature Genetics|November 11, 2024
Genetic architecture of cerebrospinal fluid and brain metabolite levels and the genetic colocalization of metabolites with human traitsCiyang Wang, Chengran Yang, Daniel Western, et al.
Research Square|June 19, 2023
Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and informs causal proteins for Alzheimer's diseaseCarlos Cruchaga, Dan Western, Jigyasha Timsina, et al.
Science Translational Medicine|July 5, 2023
Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer's diseaseYun Ju Sung, Chengran Yang, Joanne Norton, et al.
The Lancet. Neurology|May 13, 2026
Identification of genetic modifiers of autosomal dominant Alzheimer's disease: a genome-wide association studyMaulikkumar Patel, Wei Feng, Nicole S Mckay, et al.
Molecular Neurodegeneration|January 3, 2024
Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's diseaseLihua Wang, Niko-Petteri Nykänen, Daniel Western, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
CSF turnover reshapes biomarker interpretation in neurodegeneration studiesPablo García-González, Raquel Puerta, Jonas Dehairs, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Human CSF proteogenomics links genetic variation to neurodegenerative disease proteinsRaquel Puerta, Pablo Garcia-Gonzalez, Itziar de Rojas, et al.
Pageof 5